Prostate Cancer and Prostatic Diseases This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Correction to: Association between adherence to radiation therapy quality metrics and patient reported outcomes in prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 13 March 2023; doi:10.1038/s41391-023-00659-1Correction to: Association between adherence to radiation therapy quality metrics and patient reported outcomes in prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 13, 2023 Category: Urology & Nephrology Authors: Jacob E. Tallman Christopher J. D. Wallis Li-Ching Huang Zhiguo Zhao David F. Penson Tatsuki Koyama Ralph Conwill Michael Goodman Ann S. Hamilton Xiao-Cheng Wu Lisa E. Paddock Antoinette Stroup Matthew R. Cooperberg Mia Hashibe Brock B. O ’Neil Sherrie Source Type: research

Correction: Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis
Prostate Cancer and Prostatic Diseases, Published online: 10 March 2023; doi:10.1038/s41391-023-00656-4Correction: Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 10, 2023 Category: Urology & Nephrology Authors: Mike Wenzel Luigi Nocera Claudia Coll à Ruvolo Christoph W ürnschimmel Zhe Tian Shahrokh F. Shariat Fred Saad Derya Tilki Markus Graefen Luis A. Kluth Alberto Briganti Philipp Mandel Francesco Montorsi Felix K. H. Chun Pierre I. Karakiewicz Source Type: research

Correction to: Prostate volume, baseline urinary function, and their association with treatment choice and post-treatment urinary function in men treated for localized prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 08 March 2023; doi:10.1038/s41391-023-00658-2Correction to: Prostate volume, baseline urinary function, and their association with treatment choice and post-treatment urinary function in men treated for localized prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 8, 2023 Category: Urology & Nephrology Authors: Jacob E. Tallman Christopher J. D. Wallis Zhiguo Zhao Li-Ching Huang David F. Penson Tatsuki Koyama Michael Goodman Ann S. Hamilton Xiao-Cheng Wu Lisa E. Paddock Antoinette Stroup Matthew R. Cooperberg Mia Hashibe Brock B. O ’Neil Sherrie H. Kaplan Shel Source Type: research

The imperative for clinical trial diversity: Perspectives in the context of prostate-specific membrane antigen-targeted imaging
Prostate Cancer and Prostatic Diseases, Published online: 06 March 2023; doi:10.1038/s41391-023-00657-3The imperative for clinical trial diversity: Perspectives in the context of prostate-specific membrane antigen-targeted imaging (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 6, 2023 Category: Urology & Nephrology Authors: Hae Lin Cho Subha Perni Anthony V. D ’Amico Kosj Yamoah Edward Christopher Dee Source Type: research

Length of positive surgical margins after radical prostatectomy: Does size matter? – A systematic review and meta-analysis
Prostate Cancer and Prostatic Diseases, Published online: 01 March 2023; doi:10.1038/s41391-023-00654-6Length of positive surgical margins after radical prostatectomy: Does size matter? – A systematic review and meta-analysis (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 1, 2023 Category: Urology & Nephrology Authors: Athul John Alicia Lim Rick Catterwell Luke Selth Michael O ’Callaghan Source Type: research

Antimicrobial prophylaxis: To do or not to do? This is the question
Prostate Cancer and Prostatic Diseases, Published online: 28 February 2023; doi:10.1038/s41391-023-00655-5Antimicrobial prophylaxis: To do or not to do? This is the question (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 28, 2023 Category: Urology & Nephrology Authors: Tommaso Cai Source Type: research

Radiation technique and outcomes following moderately hypofractionated treatment of low risk prostate cancer: a secondary analysis of RTOG 0415
Prostate Cancer and Prostatic Diseases, Published online: 27 February 2023; doi:10.1038/s41391-023-00653-7Radiation technique and outcomes following moderately hypofractionated treatment of low risk prostate cancer: a secondary analysis of RTOG 0415 (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 27, 2023 Category: Urology & Nephrology Authors: David J. Carpenter Joseph K. Salama W. Robert Lee Matthew J. Boyer Source Type: research

Reply to: Fact, overdiagnosis cannot be evaluated by comparing histological grading of prostate biopsy to prostatectomy specimen
Prostate Cancer and Prostatic Diseases, Published online: 13 February 2023; doi:10.1038/s41391-022-00639-xReply to: Fact, overdiagnosis cannot be evaluated by comparing histological grading of prostate biopsy to prostatectomy specimen (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 13, 2023 Category: Urology & Nephrology Authors: Alberto Martini Guillaume Ploussard Source Type: research

The natural history of a delayed detectable PSA after radical prostatectomy
Prostate Cancer and Prostatic Diseases, Published online: 10 February 2023; doi:10.1038/s41391-022-00638-yThe natural history of a delayed detectable PSA after radical prostatectomy (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 10, 2023 Category: Urology & Nephrology Authors: Julie A. Szymaniak Samuel L. Washington III Janet E. Cowan Matthew R. Cooperberg Peter E. Lonergan Hao G. Nguyen Maxwell V. Meng Peter R. Carroll Source Type: research

Best of 2022 in prostate cancer and prostatic diseases
Prostate Cancer and Prostatic Diseases, Published online: 04 February 2023; doi:10.1038/s41391-023-00652-8Best of 2022 in prostate cancer and prostatic diseases (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 4, 2023 Category: Urology & Nephrology Authors: Cosimo De Nunzio Riccardo Lombardo Source Type: research

Working hard or hardly working? A brief commentary of latest research on exercise and prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 02 February 2023; doi:10.1038/s41391-023-00650-wWorking hard or hardly working? A brief commentary of latest research on exercise and prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 2, 2023 Category: Urology & Nephrology Authors: Gloria Cecilia Galv án Sanjay Das James P. Daniels Nadine A. Friedrich Stephen J. Freedland Source Type: research

A healthy diet, a healthy prostate? A brief commentary on the latest research on diet and prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 02 February 2023; doi:10.1038/s41391-023-00651-9A healthy diet, a healthy prostate? A brief commentary on the latest research on diet and prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 2, 2023 Category: Urology & Nephrology Authors: Gloria Cecilia Galv án James P. Daniels Nadine A. Friedrich Sanjay Das Stephen J. Freedland Source Type: research

Understanding biochemical recurrence after radical prostatectomy: trust biology, not a number
Prostate Cancer and Prostatic Diseases, Published online: 02 February 2023; doi:10.1038/s41391-023-00646-6Understanding biochemical recurrence after radical prostatectomy: trust biology, not a number (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 2, 2023 Category: Urology & Nephrology Authors: Simone Albisinni Romain Diamand Source Type: research

Price transparency of prostate cancer care in the United States: An analysis of pricing and disclosure following the centers for medicare and medicaid mandate
Prostate Cancer and Prostatic Diseases, Published online: 30 January 2023; doi:10.1038/s41391-023-00643-9Price transparency of prostate cancer care in the United States: An analysis of pricing and disclosure following the centers for medicare and medicaid mandate (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 30, 2023 Category: Urology & Nephrology Authors: Aaron Brant Patrick Lewicki Stephen Rhodes Camilo Arenas-Gallo Mary O. Strasser Alec Zhu Lee Ponsky Jonathan E. Shoag Source Type: research

Treatment decision-making among patients with metastatic prostate cancer: Impact of decision locus of control on functional outcomes and decision satisfaction
Prostate Cancer and Prostatic Diseases, Published online: 28 January 2023; doi:10.1038/s41391-023-00647-5Treatment decision-making among patients with metastatic prostate cancer: Impact of decision locus of control on functional outcomes and decision satisfaction (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 28, 2023 Category: Urology & Nephrology Authors: Frank A. Schumacher Irene B. Helenowski Zequn Sun Laura B. Oswald Brian D. Gonzalez Kelvin A. Moses James T. Benning Alicia K. Morgans Source Type: research